4
Changes in Ownership
PLIANT THERAPEUTICS, INC. Filed Acc 0001140361-23-003177
President and CEO sold 55,000 shares at an average $35.32 ($1,942,336)
- President and CEO acquired 30,000 shares (option exercise)
- President and CEO acquired 146,300 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coulie Bernard President and CEO | 2023-01-25 | Grant or award | +146,300 | 240,112 | D | ||
| Coulie Bernard President and CEO | 2023-01-26 | Option exercise | +15,000 | $2.08 | $31,200 | 255,112 | D |
| Coulie Bernard President and CEO | 2023-01-26 | Sale | −15,000 | $35.29 | $529,367 | 240,112 | D |
| Coulie Bernard President and CEO | 2023-01-26 | Sale | −15,000 | $35.10 | $526,425 | 419,317 | I |
| Coulie Bernard President and CEO | 2023-01-27 | Option exercise | +15,000 | $2.08 | $31,200 | 255,112 | D |
| Coulie Bernard President and CEO | 2023-01-27 | Sale | −8,698 | $35.42 | $308,046 | 246,414 | D |
| Coulie Bernard President and CEO | 2023-01-27 | Sale | −6,302 | $36.06 | $227,243 | 240,112 | D |
| Coulie Bernard President and CEO | 2023-01-27 | Sale | −9,779 | $35.09 | $343,158 | 409,538 | I |
| Coulie Bernard President and CEO | 2023-01-27 | Sale | −221 | $36.64 | $8,097 | 409,317 | I |
| Derivatives | |||||||
| Coulie Bernard President and CEO | 2023-01-25 | Grant or award · Stock Option (right to buy) | +206,300 | 206,300 | D | ||
| Coulie Bernard President and CEO | 2023-01-26 | Option exercise · Stock Option (right to buy) | −15,000 | 187,380 | D | ||
| Coulie Bernard President and CEO | 2023-01-26 | Option exercise · Stock Option (right to buy) | −15,000 | 172,380 | D | ||
| Open-market sales · 55,000 sh · avg $35.32 · $1,942,336 | |||||||
Loading xslF345X03/form4.xml…